Medscape They excluded patients with hemorrhage of nontraumatic origin, acute or chronic subdural hemorrhage, or concomitant use of anticoagulation, except for those who received subcutaneous low-molecular-weight heparin for prevention of deep-vein thrombosis ...
7thSpace Interactive (press release) IntroductionCritically ill patients often require renal replacement therapy accompanied by thrombocytopenia. Thrombocytopenia during heparin anticoagulation may be due to heparin -induced thrombocytopenia with need for alternative anticoagulation.
7thSpace Interactive (press release) IntroductionThere are approximately 19 million new cases of sepsis worldwide each year. Among them, more than one-quarter of patients die. We aimed to assess the effects of heparin on short term mortality in adult patients with sepsis and severe sepsis.
2 Minute Medicine Although the current standard of DVT prophylaxis for cancer patients is 6 months of low-molecular weight heparin (LMWH), residual vein thrombosis (RV...
pharmabiz.com Unethical practice of dispensing cheap substitutes of low molecular weight heparin to patients, suffering from cardiac arrest, is found to be flourishing in several parts of India. These products are being sold at four times the actual cost by evading ...
FiercePharma Manufacturing The FDA has kept a close eye on Chinese heparin makers ever since tainted crude heparin from China was tied to the deaths of dozens of dialysis patients in the U.S. The agency has now taken steps against a Chinese heparin maker it says is using ...
Regulatory Focus A Chinese-based manufacturer of heparin products has been sent a Warning Letter by the US Food and Drug Administration (FDA) after regulators accused the company of preventing FDA inspectors from accessing the facility earlier this year, and possibly ...
